Arteris, Inc. (NASDAQ:AIP) Vice President and General Counsel, Paul Alpern, has sold a total of 3,615 shares of the company's common stock, netting over $25,000 in the process. The transactions were executed on October 4, 2024, with a weighted average sale price of $7.13 per share.
The sale was conducted under a 10b5-1 trading plan, which Alpern had adopted earlier in the year on May 8, 2024. This type of trading plan allows company insiders to sell shares over a predetermined period of time, providing an affirmative defense against accusations of trading on nonpublic information.
According to the SEC filing, the shares were sold in multiple transactions at prices ranging from $7.05 to $7.26. Post-sale, Alpern continues to hold 68,084 shares of Arteris, indicating a maintained substantial stake in the semiconductor company.
Investors and shareholders interested in the specific breakdown of the sales prices can request detailed information from Alpern, who has agreed to provide full details about the number of shares sold at each price point within the range.
Arteris, known for its work in the semiconductor and related devices industry, has its headquarters in Campbell, California. The recent transaction by a high-level executive is part of the routine financial disclosures required by the SEC and offers investors a glimpse into insider trading activities within the company.
In other recent news, Arteris, Inc. appointed Joachim Kunkel to its Board of Directors, bringing over three decades of experience from his time at Synopsys (NASDAQ:SNPS) and CADIS GmbH. In the financial realm, Arteris reported a strong Q2 performance with an annual contract value plus royalties of $60.1 million, total revenue for the quarter at $14.6 million, and a positive free cash flow of $300,000. The company attributed this success to the addition of seven new customers, the signing of four new license deals, and 21 confirmed design starts in the AI-enabled autonomous driving sector.
Looking ahead, Arteris projects its annual contract value plus royalties to range between $58.5 million and $62.5 million for Q3, with revenues expected to be between $14.2 million and $15.2 million. For the full year of 2024, the company's guidance includes an annual contract value plus royalties of $62 million to $68 million and revenue of $56 million to $58 million. These recent developments indicate a positive trajectory for Arteris, Inc. in the semiconductor industry.
InvestingPro Insights
As Arteris (NASDAQ:AIP) Vice President and General Counsel Paul Alpern sells a portion of his shares, investors might be curious about the company's financial health and market position. According to InvestingPro data, Arteris has a market capitalization of $281.47 million, reflecting its position in the semiconductor industry.
One of the InvestingPro Tips highlights that Arteris holds more cash than debt on its balance sheet, which could be seen as a positive sign of financial stability, especially important in the capital-intensive semiconductor sector. This strong cash position may provide the company with flexibility for future investments or to weather potential industry downturns.
Another InvestingPro Tip notes that Arteris boasts impressive gross profit margins, which is supported by the data showing a gross profit margin of 89.39% for the last twelve months as of Q2 2024. This high margin suggests that the company has significant pricing power for its products or efficient cost management in its core operations.
However, it's worth noting that despite these strengths, Arteris is not currently profitable, with a negative P/E ratio of -7.64 for the last twelve months as of Q2 2024. This aligns with another InvestingPro Tip indicating that analysts do not anticipate the company to be profitable this year.
For investors seeking a more comprehensive analysis, InvestingPro offers additional insights with 7 more tips available for Arteris, which could provide a fuller picture of the company's prospects and challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.